Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × oprelvekin × Clear all

Phase

Status

Completed 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

CTIT: Cancer Therapy Induced Thrombocytopenia 1

Interventions

Magnetic Resonance Spectroscopy 323 Specimen Handling 320 Radiotherapy 317 Cyclophosphamide 292 pembrolizumab 287 Cisplatin 262 Carboplatin 245 Blood Specimen Collection 238 Drug Therapy 237 Biopsy 197 Bevacizumab 182 Gemcitabine 178 venetoclax 175 Radiosurgery 165 Oxaliplatin 157 Nivolumab 157 fludarabine 154 Paclitaxel 154 Capecitabine 152 Standard of Care 139 Surgical Procedures, Operative 130 Surveys and Questionnaires 129 Dexamethasone 127 Fluorouracil 123 Rituximab 111 Docetaxel 111 tislelizumab 109 Cytarabine 106 Radiation 103 durvalumab 99

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06759636 2026-04-14

FRIENDS-01

The First Affiliated Hospital with Nanjing Medical University

Phase 3 Recruiting

Classical hematology

CTIT: Cancer Therapy Induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡